Neil Hackett, PhD, is an independent consultant based in New York City with extensive experience in pre-clinical and translational programs for gene therapy. He currently works with research groups and foundations to navigate stem cell and gene therapy projects through pre-investigational to new drug applications (IND). This includes project management, advising on proof-of-concept and toxicology studies, vector manufacturing and regulatory writing. His background includes professorial appointments at Vanderbilt University and Weill Cornell Medical College resulting in more than 100 academic publications. Dr. Hackett is a genetic consultant for Fondazione CHOPS.